Body and Mind

The first aceclidine-based eye drop to improve near vision in adults with age-related presbyopia, which affects more than 100 million adults in the US alone, has been approved by the Food and Drug Administration and will be on sale by November.

In a new study from the University of Oregon, scientists turned up the temperature to see which type of passive heat therapy packs the most health punch – hot baths, traditional saunas, or those fancy far-infrared saunas.

Adding to the growing body of research that proves our microbiome is a powerful ally in fighting disease, scientists have found that an easy-to-get nutrient in our food causes our guts to produce powerful insulin-regulating compounds.

For the first time, researchers have linked a gene thought to be responsible for ulcerative colitis with a mechanism of attack, opening the way to new diagnostic tools and opportunities for more targeted treatment.

The US has broken a two-decade drought with the Food and Drug Administration adding bemotrizinol to the list of approved active ingredients that can be used in sunscreen, paving the way for more effective protection from ultraviolet radiation.

A novel way to brew coffee without boiling water or high pressure harnesses the power of sound waves, slashing time and energy.

People with Alzheimer’s disease who took the over-the-counter supplement glucosamine were 25% more likely to die within five years than those who didn’t. This new study investigates its role in speeding up cognitive decline.

Researchers at the University of Cambridge have developed what they describe as a fundamentally new type of vaccine. The vaccine’s key component was designed entirely by AI and has now been tested in people for the first time.

In the US, 6,000 women enter menopause every day, or 1.3 million in a year. Now, a study sheds light on the brain connectivity changes that happen in this phase, paving the way to finally understanding and ideally treating midlife cognitive decline.

Many people manage their symptoms with antihistamines bought from a pharmacy. But recent headlines have raised a worrying question: could some of the medicines used to relieve hay fever symptoms increase the risk of dementia?

A new study suggests that as many as 20% of Parkinson's disease cases may be something else entirely, highlighting the importance of test accuracy before treatment is even on the cards. As to why it's been misdiagnosed – well, it's complicated.

Does the way information "sticks" to our brains differ depending on the medium? New research suggests it might, with readers engaging more with a story in a traditional book than one read on a digital device.

A team of researchers from George Mason University in Virginia, US, has developed a new model to simulate the team dynamics and group behaviours associated with long-term space travel.

People who don’t like to work out will sometimes joke that they’re “allergic” to exercise. But what many don’t realise is that an allergy to exercise is a real thing – and it can be dangerous if not caught in time.

A medication commonly given as an off-label treatment for sleep problems may be more risky than thought – and although it's prescribed for obstructive sleep apnea or insomnia, as it often is, we lack the science data needed for safe and informed use.

If you follow wellness channels on social media, you might’ve come across the claim that your grip strength – or how firmly you can squeeze something with your hands – can predict how long you will live.

Circumcision may soon be fully reversible. That’s the goal of Foregen, a nonprofit organization dedicated to making the first viable bio-engineered foreskin using advanced tissue engineering.

The current Ebola outbreak is the third-largest in world history, with 906 suspected cases and 223 deaths in the DRC alone as of 27 May.